ARID4B and myocardial infarction: Since an improved cardiac insulin signalling was observed in MI hearts post mAb A treatment (Fig. 5) concomitantly with an inhibition in the hypertrophic signal (Fig. 2), we assessed whether these modifications were associated with any alterations in cardiac BCAA catabolism.